Applicant, as named in the Orange Book

Antares Pharma Inc

Next listed expiry: Xyosted (Autoinjector) on 4 Sep 2036. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xyosted (Autoinjector) · 3 strengths testosterone enanthate	testosterone enanthate	209863	4 Sep 2036	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.